Skip to main content

Feature

Olympics: Claims from the games

Terrorism, adverse weather and the outbreak of disease could all cause the cancellation of the Olympics. But could the industry cope if the Games were canned?

IMD2 - a level playing field?

Legislative proposals released this month by the European Commission for the Insurance Mediation Directive have met with mixed reviews. Victor Fornasier asks whether they will finally create a level playing field.

Asia’s next big growth market

Asia-Pacific is still very much the place to be in insurance terms but as Jenni Marsh reports the less traditional markets, outside of China and Japan, are expected to be the real growth stories in the coming years.

Mandatory commission – an necessary evil?

Rumors of mandatory commission disclosure have plagued the market since the start of the year but as the European Commission confirms brokers fears Francesca Nyman assesses the impact on European brokers.

Legal Update: Migrant Workers - Claims farming

The harvest season in the UK inevitably means a rise in migrant workers in the agricultural sector. The need to navigate questions of ethics, potential conflicts of interest and policy breaches means insurers must scrutinise related claims carefully

Broking Focus: Bespoke tailoring

Biba’s wants the strategic review of its operations by Deloitte to produce a trade body fit to compete alongside the strongest organisations in the 21st century

High Net Worth: Join The High Flyers

With the lucrative high net worth market continuing to soar, it’s little wonder so many new entrants are getting on board – but there could be a hard landing ahead for some

A mutual future?

Regulations like Solvency II will have a significant impact on mutuals across Europe. Francesca Nyman asks whether the model will survive.

Accounting Standards: Slow but steady

Eight years since the 'interim' International Financial Reporting Standards were introduced, progress is still slow on final implementation.

Spotlight On Medical & Health: Trial and error

Clinical trials on humans is witnessing great technological advances, but they can be dangerous, as the Te Genero case proved in 2006. With compulsory insurance required, how can insurers manage the risks involved?

Loss adjusting: A standards issue

Direct regulation of loss adjusters has been on the agenda for more than a decade but, with Europe ready to step in, is the industry prepared to be governed by forces on the continent?

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here